StockComparison Logo
vs

HIND vs SNSE

Comparison between ReShape Lifesciences Inc (HIND, Company) and Sensei Biotherapeutics Inc (SNSE, Company).

Both HIND and SNSE are from the Healthcare sector.

5-Year PerformanceSNSE has outperformed HIND, delivering a return of -43.6% compared to -93.4%

HIND vs SNSE - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
HIND
$15M
Winner
SNSE
$15M
Max Drawdown
HIND
100.00%
Winner
SNSE
98.73%
Sharpe Ratio
HIND
-0.84
Winner
SNSE
0.98
5Y Beta
Winner
HIND
0.00
SNSE
1.16
Industry
HIND
Biotechnology
SNSE
Biotechnology
P/E Ratio
Winner
HIND
-0.54
SNSE
-0.08
PEG Ratio
HIND
N/A
SNSE
-0.00
Debt to Equity
HIND
0.00%
SNSE
0.00%
Free Cash Flow Yield
HIND
-20.08%
SNSE
N/A
P/S Ratio
HIND
99.95
SNSE
N/A
P/B Ratio
HIND
2.26
Winner
SNSE
1.26

HIND vs SNSE - Historical Returns

Returns include dividend reinvestment.

1M
Winner
HIND
+15.34%
SNSE
-28.88%
3M
Winner
HIND
+2.83%
SNSE
-51.40%
6M
HIND
-44.95%
Winner
SNSE
+79.83%
1Y
HIND
-79.59%
Winner
SNSE
+122.85%
5Y(CAGR)
HIND
-93.38%
Winner
SNSE
-43.59%
10Y(CAGR)
HIND
-82.34%
SNSE
N/A
Max(CAGR)
HIND
-82.34%
Winner
SNSE
-45.55%

HIND vs SNSE - Annual Returns (2016 - 2026)

Returns include dividend reinvestment.

YearHINDSNSE
2026-38.59%+50.65%
2025-99.25%+3.59%
2024-71.18%-37.68%
2023-98.41%-51.94%
2022-92.75%-75.45%
2021+13.10%-69.31%
2020-20.21%N/A
2019-91.74%N/A
2018-71.05%N/A
2017-27.84%N/A
2016-41.00%N/A

HIND vs SNSE Drawdown Comparison

The maximum drawdown for HIND was -100.00%, occurring on May 15, 2026. This drawdown has not yet recovered.

The maximum drawdown for SNSE was -98.73%, occurring on Apr 4, 2025. This drawdown has not yet recovered.

The current HIND drawdown is -100.00%. The current SNSE drawdown is -96.81%.

RankHINDSNSE
#1-100.00%
Oct 6, 2016 - May 15, 2026
-98.73%
Feb 8, 2021 - Apr 4, 2025

Correlation

Correlation between HIND and SNSE is 0.91 which considered as a very strong positive correlation - the stocks move almost identically together.

0.91
-101

Select Stocks to Compare